4th Annual Nordic-American Life Science Conference

About
The 4th Nordic-American Life Science Conference (NALS) on 4–5 December at Shearman & Sterling (day 1) and WellSaid, Convene (day 2) in New York, will feature company presentations from some of the leading healthcare companies in the Nordics, panel discussions and inspiring keynote speakers. The NALS conference attracts private and publicly listed Nordic healthcare companies and life science organisations, institutional and private investors, innovation scouts and other industry participants.
Hosted and sponsored by
![]() |
![]() |
![]() |
![]() |
The agenda
Day 1: Expert panels and networking sessions at Shearman & Sterling, 599 Lexington Avenue, New York |
Day 2: Listed company presentations at WellSaid, Convene, 151 West 42nd Street, New York |
||
The first day offers panel discussions, group presentations and interactive workshops from industry experts. The goal is to provide insights on topics relevant to life science companies that wish to raise capital, enter into partnering and licensing deals and potentially sell their solutions on the US markets. |
The second day will feature company presentations from listed Nordic companies, high-profile keynote speakers and a private company track with late-stage/pre-IPO companies. One-to-one meetings with management will be offered to investors. |
||
Summary
Event: 4th Annual Nordic-American Life Science Conference
Date: 4–5 December, 2019
Location: Shearman & Sterling/WellSaid, Convene, New York
co-hosted by: DNB, Business Sweden, Nasdaq and Edison
About: This two-day conference will feature company presentations from some of the leading healthcare companies in the Nordics, panel discussions and inspiring keynote speakers. The NALS conference attracts private and publicly listed Nordic healthcare companies and life science organisations, institutional and private investors, innovation scouts and other industry participants.
For more information and to register your interest, email Ethan.